Yale University School of Medicine, Department of Laboratory Medicine, New Haven, CT, USA.
Puget Sound Blood Center Research Institute, Seattle, WA, USA ; University of Washington, Department of Laboratory Medicine, Seattle, WA, USA.
Transfus Med Hemother. 2014 Nov;41(6):406-19. doi: 10.1159/000368995. Epub 2014 Nov 17.
Red blood cell (RBC) alloimmunization may occur following transfusion or pregnancy/delivery. Although observational human studies have described the immunogenicity of RBC antigens and the clinical significance of RBC alloantibodies, studies of factors influencing RBC alloimmunization in humans are inherently limited by the large number of independent variables involved. This manuscript reviews data generated in murine models that utilize transgenic donor mice, which express RBC-specific model or authentic human blood group antigens. Transfusion of RBCs from such donors into nontransgenic but otherwise genetically identical recipient mice allows for the investigation of individual donor or recipient-specific variables that may impact RBC alloimmunization. Potential donor-related variables include methods of blood product collection, processing and storage, donor-specific characteristics, RBC antigen-specific factors, and others. Potential recipient-related variables include genetic factors (MHC/HLA type and polymorphisms of immunoregulatory genes), immune activation status, phenotype of regulatory immune cell subsets, immune cell functional characteristics, prior antigen exposures, and others. Although murine models are not perfect surrogates for human biology, these models generate phenomenological and mechanistic hypotheses of RBC alloimmunization and lay the groundwork for follow-up human studies. Long-term goals include improving transfusion safety and minimizing the morbidity/mortality associated with RBC alloimmunization.
红细胞(RBC)同种免疫可能发生在输血或妊娠/分娩后。尽管观察性人类研究已经描述了 RBC 抗原的免疫原性和 RBC 同种抗体的临床意义,但影响人类 RBC 同种免疫的因素的研究受到所涉及的大量独立变量的固有限制。本文综述了利用表达 RBC 特异性模型或真实人类血型抗原的转基因供体小鼠的鼠模型中产生的数据。将来自这些供体的 RBC 输注到非转基因但在遗传上完全相同的受体小鼠中,允许研究可能影响 RBC 同种免疫的个体供体或受体特异性变量。潜在的供体相关变量包括血液制品采集、处理和储存的方法、供体特异性特征、RBC 抗原特异性因素等。潜在的受体相关变量包括遗传因素(MHC/HLA 类型和免疫调节基因的多态性)、免疫激活状态、调节性免疫细胞亚群的表型、免疫细胞功能特征、先前的抗原暴露等。尽管鼠模型不是人类生物学的完美替代品,但这些模型产生了 RBC 同种免疫的现象学和机制假设,并为后续的人类研究奠定了基础。长期目标包括提高输血安全性和最大限度地降低与 RBC 同种免疫相关的发病率/死亡率。